Cargando…

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care

Although familial hypercholesterolemia (FH) screening within primary care is considered cost-effective, which screening approach is cost-effective has not been established. This study determines the cost-effectiveness of six case-finding strategies for screening of electronic health records to ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Matthew, Akyea, Ralph K., Payne, Katherine, Humphries, Steve E., Abdul-Hamid, Hasidah, Weng, Stephen, Qureshi, Nadeem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953997/ https://www.ncbi.nlm.nih.gov/pubmed/35330330 http://dx.doi.org/10.3390/jpm12030330

Ejemplares similares

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care
por: Weng, Stephen, et al.
Publicado: (2019)

Systematic Identification of Familial Hypercholesterolaemia in Primary Care—A Systematic Review
por: Silva, Luisa, et al.
Publicado: (2021)

Performance and clinical utility of supervised machine-learning approaches in detecting familial hypercholesterolaemia in primary care
por: Akyea, Ralph K., et al.
Publicado: (2020)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)

Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients
por: Mohammadnia, Niekbachsh, et al.
Publicado: (2022)

Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study
por: Akyea, Ralph K, et al.
Publicado: (2020)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study
por: Qureshi, Nadeem, et al.
Publicado: (2016)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Hiding in plain sight: supporting primary care to find familial hypercholesterolaemia and save lives
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience
por: Silva, Luisa, et al.
Publicado: (2022)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records
por: Iyen, Barbara, et al.
Publicado: (2020)

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Futema, Marta, et al.
Publicado: (2017)

Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse‐led clinics
por: Green, Peter, et al.
Publicado: (2015)

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
por: Futema, Marta, et al.
Publicado: (2012)

Identifying Patients with Bicuspid Aortic Valve Disease in UK Primary Care: A Case–Control Study and Prediction Model
por: Evans, William, et al.
Publicado: (2022)

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
por: Humphries, Steve E., et al.
Publicado: (2018)

Early identification of familial hypercholesterolaemia in general practice using patient-specific reminders: focus group with General Practitioners
por: Tranter, Jennifer, et al.
Publicado: (2014)

Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia
por: Khamis, Amna, et al.
Publicado: (2015)

Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2018)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2014)

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
por: Humphries, Steve E., et al.
Publicado: (2019)

The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2021)

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019)

Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK
por: Iyen, Barbara, et al.
Publicado: (2021)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study
por: Seed, Mary, et al.
Publicado: (2012)

Obesity and long‐term outcomes after incident stroke: a prospective population‐based cohort study
por: Akyea, Ralph K., et al.
Publicado: (2021)

Screening for potential familial hypercholesterolaemia in general practice: an observational study on prevalence and management
por: Mülverstedt, Stefan, et al.
Publicado: (2021)

Screening for familial hypercholesterolaemia in primary school children: protocol for a cross-sectional, feasibility study in Luxembourg city (EARLIE)
por: Becker, Marianne, et al.
Publicado: (2022)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
por: Sarkies, Mitchell, et al.
Publicado: (2023)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v55h16ihhkjqotq32bblb6mehn